Ruslan Cusnir

Dr. Ruslan Cusnir

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RCRuslan Cusnir
Ruslan Cusnir
CICinzia Imberti
Cinzia Imberti
RHRobert Charles Hider
Robert Charles Hider
PBPhil Blower
Phil Blower
MMMichelle Ma
Michelle Ma
Derivatives of 3,4-hydroxypyridinones have been extensively studied for in vivo Fe3+ sequestration. Deferiprone, a 1,2-dimethyl-3,4-hydroxypyridinone, is now routinely used for clinical treatment of iron overload disease. Hexadentate tris(3,4-hydroxypyridinone) ligands (THP) complex Fe3+ at very low iron concentrations, and their high affinities for oxophilic trivalent metal ions have led to their development for new applications as bifunctional chelators for the positron emitting radiometal, 68Ga3+, which is clinically used for molecular imaging in positron emission tomography (PET). THP-peptide bioconjugates rapidly and quantitatively complex 68Ga3+ at ambient temperature, neutral pH and micromolar concentrations of ligand, making them amenable to kit-based radiosynthesis of 68Ga PET radiopharmaceuticals. 68Ga-labelled THP-peptides accumulate at target tissue in vivo, and are excreted largely via a renal pathway, providing high quality PET images.

14 November 2019 in RSC Advances
Verified
Journal Article
Open access
PDF file
RCRuslan Cusnir
Ruslan Cusnir
ACAndrew Cakebread
Andrew Cakebread
MCMargaret S. Cooper
Margaret S. Cooper
JYJennifer D. Young
Jennifer D. Young
PBPhil Blower
Phil Blower
MMMichelle Ma
Michelle Ma
We have quantified trace metal impurities present in 68 Ga generator eluant from the widely used Eckert & Ziegler 68 Ga generator, and measured the effect of these metal impurities on 68 Ga radiolabelling of a THP chelator.

20 August 2014 in Environmental Science & Technology
Verified
Journal Article
Closed access
RCRuslan Cusnir
Ruslan Cusnir
PSPhilipp Steinmann
Philipp Steinmann
FBFrançois Bochud
François Bochud
PFPascal Froidevaux
Pascal Froidevaux

26 April 2016 in Environmental Science & Technology
Verified
Journal Article
Closed access
RCRuslan Cusnir
Ruslan Cusnir
MJMaud Jaccard
Maud Jaccard
CBClaude Bailat
Claude Bailat
MCMarcus Christl
Marcus Christl
PSPhilipp Steinmann
Philipp Steinmann
PFPascal Froidevaux
Pascal Froidevaux

11 October 2021 in EJNMMI Radiopharmacy and Chemistry
Verified
Journal Article
Open access
PDF file
RCRuslan Cusnir
Ruslan Cusnir
MLMichel Leresche
Michel Leresche
CPClaude Pilloud
Claude Pilloud
MSMarietta Straub
Marietta Straub
Background: Nanocolloidal human serum albumin radiolabelled with 99mTc provides a diagnostic radiopharmaceutical for sentinel node lymphoscintigraphy. NanoHSA (Nanotop), a commercially available kit, enables the simple preparation of this radiopharmaceutical via reconstitution with pertechnetate eluted from a generator. Thin-layer chromatography is widely used for determining radiochemical purity in clinical nuclear medicine. Quality control methods recommended by the manufacturer were sometimes reported to yield variable results. Therefore, we proposed and evaluated three alternative thin-layer chromatography methods for the quality control of [99mTc]Tc-NanoHSA from a commercially available kit. Results: The radiochemical purity of [99mTc]Tc-NanoHSA determined with all methods was reproducible and met the requirements of the SPC and the European Pharmacopoeia (≥ 95%). Our quality control using iTLC-SG chromatographic paper in methyl ethyl ketone mobile phase identified only free pertechnetate as impurity, resulting in > 99% RCP. The quality control using iTLC-SG in 85% methanol or iTLC-SA in 0.9% NaCl identified an additional small fraction of a hydrophilic impurity, resulting in 95–97% RCP. Glucose was identified as a potential 99mTc-carrying hydrophilic species contributing to hydrophilic impurities. Conclusion: Our quality control of [99mTc]Tc-NanoHSA with non-polar mobile phase tended to underestimate the amount of hydrophilic impurities, although without compromising the final quality of the radiopharmaceutical. Alternative TLC methods using aqueous mobile phases enabled a more accurate determination of hydrophilic impurities.

1 January 2022 in Analytica Chimica Acta
Verified
Journal Article
Open access
RCRuslan Cusnir
Ruslan Cusnir
PFPascal Froidevaux
Pascal Froidevaux
PCPierre Carbonez
Pierre Carbonez
MSMarietta Straub
Marietta Straub
Actinium-225 is a highly radiotoxic alpha-emitting radionuclide, which is currently in the spotlight owing to its promising radiotherapeutic applications in nuclear medicine. Personnel involved in the production and handling of actinium-225 is exposed to a risk of accidental incorporation of this radionuclide. Radiological protection regulations require regular monitoring of incorporation and internal dosimetry assessment for workers manipulating open radioactive sources. Urine is often used as a biological sample for measuring the incorporation of actinides, however it requires a radiochemical separation with a certified metrological tracer to enable quantitative determination. There is no stable, nor sufficiently long-lived radioactive isotopes of actinium to provide a metrological yield tracer. In this article, we propose an application of an ion-imprinted polymer resin to extract actinium-225 from urine employing americium-243 as a radioactive tracer. The radiochemical separation was followed by a quantitative determination with alpha-spectrometry. Solid-phase extraction of both actinides from urine using ion-imprinted polymer resin resulted in good radiochemical yields: 57.7 +/- 16.5% (n = 17) for actinium-225 and 62.8 +/- 18.0% (n = 17) for americium-243. Equivalent recoveries showed that americium-243 is a suitable yield tracer for the determination of actinium-225 with an ion-imprinted polymer resin. Combined with a different measurement technique, this method can be applied for the separation of other isotopes of actinium, such as actinium-227. (c) 2022 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).